Wyndham Washington Hotel
1400 M Street, NW
Washington, DC 20005
202-429-1700
9:00 am | Session
1: The Meaning of Federal Funding.
Peter Berkowitz, Associate Professor of Law, George
Mason University Law School; Research Fellow, the Hoover
Institution; and Senior Consultant, the President’s
Council on Bioethics. |
10:30 am | Break |
10:45 am | Session
2: Stem Cells: The Administration’s Funding Policy:
Legal and Moral Foundations
Discussion of Staff Working Paper, “The Administration’s
Stem Cell Research Funding Policy: Legal and Moral Foundations.” |
12:15 pm | Lunch |
2:00 pm | Session 3: Stem Cells: Moving Research from the Bench toward the Bedside: The Role of NIH and FDA Part I (60 min.): Elias A. Zerhouni, M.D., Director,
|
3:30 pm | Break |
3:45 pm | Session
4: Stem Cells: Moving Research from the Bench toward
the Bedside: The Role of Nongovernmental Activity.
Thomas Okarma, President and CEO, Geron Corporation. |
5:15 pm | Adjournment |
8:30 am | Session 5: Biotechnology & Public Policy: Proposed Interim Recommendations, I. Discussion of Parts I and II of Staff Working Paper,
“U.S. Public Policy and the Biotechnologies that Touch
the Beginnings of Human Life: Draft Recommendations.”
|
10:00 am | Break |
10:15 am | Session
6: Biotechnology & Public Policy: Proposed Interim Recommendations,
II.
Discussion of Part III of Staff Working Paper, “U.S. Public Policy and the Biotechnologies that Touch the Beginnings of Human Life: Draft Recommendations." |
11:30 am | Session
7: Public Comments |
12:30 pm | Adjournment |